Evidence map›Paper›PMID 40261605›Full record

ArticleMolecular neurobiology2025

Insight into Apert Syndrome: Reporting on Six Patients and Increasing Awareness.

Hala T El-Bassyouni, Ghada Y El-Kamah, Hanan H Afifi, Mohamed B Taher, Doaa R Soliman, Khaled Hamed, Mennat I Mehrez, Khalda Sayed Amr

Abstract readCase Reports
In one paragraph

Article in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hala T El-BassyouniDepartment of Clinical Genetics, National Research Centre, Cairo, Egypt. halabassyouni@yahoo.com.ORCID http://orcid.org/0000-0001-9825-1219
Ghada Y El-KamahDepartment of Clinical Genetics, National Research Centre, Cairo, Egypt.
Hanan H AfifiDepartment of Clinical Genetics, National Research Centre, Cairo, Egypt.
Mohamed B TaherDepartment of Clinical Genetics, National Research Centre, Cairo, Egypt.
Doaa R SolimanDepartment of Pediatrics, Faculty of Medicine, Benha University, Benha, Egypt.
Khaled HamedDepartment of Clinical Genetics, National Research Centre, Cairo, Egypt.
Mennat I MehrezDepartment of Oro-Dental Genetics, National Research Centre, Cairo, Egypt.
Khalda Sayed AmrDepartment of Molecular Genetics, National Research Centre, Cairo, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Apert syndrome (AS) is a rare autosomal dominant disorder characterized by various congenital malformations. In this study, we aimed to explore the clinical presentation of Apert syndrome to enhance awareness among multidisciplinary healthcare providers regarding its differential diagnosis through the phenotype/genotype characterization of six Egyptian patients with AS. We examined six patients with Apert syndrome: four females and two males (2:1), aged 3 to 7 years. Clinical examination, along with pedigree analysis, was followed by DNA extraction from the patients' and their parents' peripheral blood leukocytes for genomic screening of FGFR2 gene variations. Key findings in all patients included craniosynostosis and distinctive facial features such as midface hypoplasia, exophthalmos, hypertelorism, a beaked nose, a prominent forehead, and an underdeveloped upper jaw, along with syndactyly of the hands and feet. We identified oral anomalies such as cleft palate, bifid uvula, impacted teeth, delayed eruption, supernumerary teeth, and thick gingiva. Pathogenic variants of the FGFR2 gene were characterized in all six patients. This report presents the largest cohort of Apert syndrome among Egyptian patients. Raising awareness about AS, especially among various interdisciplinary teams, is essential for managing this rare condition and is crucial for accurate diagnosis and timely medical and surgical intervention. Proper diagnosis and genetic counseling are necessary for improving survival and preventing the recurrence of complications.

Indexed as

AcrocephalosyndactyliaAwarenessChildChild, PreschoolFemaleHumansMalePedigreePhenotypeReceptor, Fibroblast Growth Factor, Type 2FGFR2 protein, humanReceptor, Fibroblast Growth Factor, Type 2Apert syndromeCraniosynostosisDental anomaliesFGFR2Syndactyly

Identifiers

PMID40261605
PMCPMC12367812

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.